Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7531167 Herpes simplex virus vector

Patent 7531167 was granted and assigned to University of Pittsburgh on May, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

University of Pittsburgh

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David Krisky0

Darren Wolfe0

Joseph C. Glorioso0

Date of Patent

May 12, 2009

0

Patent Application Number

116941180

Date Filed

March 30, 2007

0

Patent Citations Received

US Patent 11918660 Viral vectors for cancer therapy

0

US Patent 11865081 Oncolytic viral delivery of therapeutic polypeptides

0

US Patent 11779660 Viral vectors for cancer therapy

US Patent 11865148 Methods of delivering transgenes to the eye

0

US Patent 11883448 Oncolytic HSV vector

0

US Patent 12134790 Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)

0

US Patent 12128122 Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic

0

Patent Primary Examiner

Michael C. Wilson

0

Patent abstract

The invention provides a herpes simplex virus vector comprising deletions in ICP4, ICP27, and UL55.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7531167 Herpes simplex virus vector

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool